FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Site helps visitors find trials

Tools

With a paucity of participants in clinical trials among the factors in lengthening the development timeline for new drugs, contract research giant Quintiles has opened ClinicalResearch.com, an Internet site that simplifies the process of finding a trial.

"Research shows that 75 percentof the public state they have little or no knowledge of clinical research and the participation process," says Chris Cabell, head of global access to patients, in an announcement. "If patients and their families are more aware of the opportunities, they will be better able to make informed decisions about participating."

Site visitors can identify ongoing and future trials related to their disease or condition and narrow them down to those that are geographically feasible. Supporting information about clinical research includes videos describing patient experiences and news from recent studies.

Internet sites aren't the only tool helping investigators get their trials off the ground. As reported earlier, an iPhone application debuted in August from start-up Healogica, which has developed a monster.com-like matching service for investigators and would-be subjects. And in April, healthcare IT start-up TrialX launched an application that allows Twitter users to find trials.

- see the release
- visit the Internet site
- here's our Healogica coverage
- read the TrialX item

Bookmark and Share
Get Your FREE FierceBiotechIT Email Newsletter:
Comments (1) | Post a comment
More stories about website   subject recruitment   Internet Sites   clinical trials   Clinical Research  

Comments

I am delighted that Quintiles set up a website - ClincalResearch.com to help educate the public about clinical trials. I would like to add that another potential barrier to clinical trial participation relates to insurance. People are concerned about the costs of their participation, and how this affects their insurance. I think that the current health care reform debate needs to also address this important issue of clinical trials. Insurers, whether public or private, need to understand that participation in clinical trials is Good Medicine, and should not be exluded.

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.